HU9503934D0 - Bicyclic tetrahydro pyrazolopyridines - Google Patents

Bicyclic tetrahydro pyrazolopyridines

Info

Publication number
HU9503934D0
HU9503934D0 HU9503934A HU9503934A HU9503934D0 HU 9503934 D0 HU9503934 D0 HU 9503934D0 HU 9503934 A HU9503934 A HU 9503934A HU 9503934 A HU9503934 A HU 9503934A HU 9503934 D0 HU9503934 D0 HU 9503934D0
Authority
HU
Hungary
Prior art keywords
pyrazolopyridines
bicyclic
bicyclic tetrahydro
tetrahydro pyrazolopyridines
tetrahydro
Prior art date
Application number
HU9503934A
Other languages
Hungarian (hu)
Other versions
HUT74170A (en
Inventor
Allen Jacob Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9503934D0 publication Critical patent/HU9503934D0/en
Publication of HUT74170A publication Critical patent/HUT74170A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9503934A 1993-07-06 1994-06-16 Bicyclic tetrahydro pyrazolopyridines HUT74170A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8829293A 1993-07-06 1993-07-06

Publications (2)

Publication Number Publication Date
HU9503934D0 true HU9503934D0 (en) 1996-03-28
HUT74170A HUT74170A (en) 1996-11-28

Family

ID=22210524

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503934A HUT74170A (en) 1993-07-06 1994-06-16 Bicyclic tetrahydro pyrazolopyridines

Country Status (20)

Country Link
EP (1) EP0707585A1 (en)
JP (1) JP2944048B2 (en)
KR (1) KR100228949B1 (en)
CN (1) CN1048015C (en)
AU (1) AU695301B2 (en)
BR (1) BR9406946A (en)
CA (1) CA2166721C (en)
CZ (1) CZ3696A3 (en)
EG (1) EG20513A (en)
FI (1) FI943208A (en)
HU (1) HUT74170A (en)
IL (1) IL110175A (en)
MX (1) MX9405132A (en)
NO (1) NO305029B1 (en)
NZ (1) NZ266525A (en)
PL (1) PL312426A1 (en)
RU (1) RU2131876C1 (en)
TW (1) TW316904B (en)
WO (1) WO1995001980A1 (en)
ZA (1) ZA944844B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012720A1 (en) * 1994-10-20 1996-05-02 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
JP3107827B2 (en) * 1995-06-06 2000-11-13 ファイザー・インコーポレーテッド Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-c] -1,2,4-triazolo [4,3-a] pyridines
AP932A (en) * 1996-08-26 2001-02-02 Pfizer Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
YU11299A (en) * 1996-09-04 2001-07-10 Pfizer Inc. Indasole derivatives
KR100628407B1 (en) 1998-12-23 2006-09-26 브리스톨-마이어스 스퀴브 파마 컴파니 Nitrogen Containing Heterobicycles as Factor XA Inhibitors
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
TWI243055B (en) * 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
MXPA03001169A (en) * 2000-08-10 2003-06-30 Pharmacia Italia Spa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
US6960595B2 (en) * 2001-03-23 2005-11-01 Bristol-Myers Squibb Pharma Company 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
CA2444571A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1, 4, 5, 6-tetrahydropyrazolo-¬3, 4-c|-pyridin-7-ones as factor xa inhi bitors
CA2441772A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors
US7902179B2 (en) 2001-04-26 2011-03-08 Ajinomoto Co., Inc. Heterocyclic compounds
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CL2004000398A1 (en) 2003-02-27 2005-03-18 Uriach Y Compania S A J COMPOUNDS DERIVED FROM PIRAZOLOPIRIDINAS, ITS SALTS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT DISEASES MEDIATED BY P38 KINASES, ESPECIALLY BY CITOCINES, TNF-ALFA, IL-1, IL-6 AND / OR IL-8, SUCH AS DISEASE
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
DE102005031580A1 (en) * 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituted sulfolanylpyrazoles and their use
PE20081889A1 (en) * 2007-03-23 2009-03-05 Smithkline Beecham Corp INDOL CARBOXAMIDES AS INHIBITORS OF IKK2
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (en) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2522968T3 (en) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (en) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド Method for preparing guanylate cyclase C agonist
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists and uses thereof
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
JP6694385B2 (en) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド Compounds and methods for inhibiting phosphate transport
CN110357888A (en) * 2018-04-09 2019-10-22 南京药捷安康生物科技有限公司 Heterocycle phosphodiesterase inhibitors and application thereof
JP2022533251A (en) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド Combinations to lower serum phosphate in patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
FR1463883A (en) * 1964-09-08 1966-07-22 Ciba Geigy Process for the preparation of bicyclic triaza-compounds
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
CA2166721A1 (en) 1995-01-19
AU6805794A (en) 1995-02-06
EP0707585A1 (en) 1996-04-24
JP2944048B2 (en) 1999-08-30
JPH08507084A (en) 1996-07-30
NO305029B1 (en) 1999-03-22
IL110175A0 (en) 1994-10-07
FI943208A0 (en) 1994-07-05
CN1048015C (en) 2000-01-05
CN1129940A (en) 1996-08-28
KR100228949B1 (en) 1999-11-01
PL312426A1 (en) 1996-04-29
CA2166721C (en) 1999-07-27
WO1995001980A1 (en) 1995-01-19
NZ266525A (en) 1997-10-24
CZ3696A3 (en) 1997-06-11
NO960056D0 (en) 1996-01-05
RU2131876C1 (en) 1999-06-20
KR960703852A (en) 1996-08-31
TW316904B (en) 1997-10-01
MX9405132A (en) 1995-01-31
NO960056L (en) 1996-01-05
FI943208A (en) 1995-01-07
BR9406946A (en) 1996-08-06
EG20513A (en) 1999-06-30
IL110175A (en) 2000-01-31
AU695301B2 (en) 1998-08-13
ZA944844B (en) 1996-01-05
HUT74170A (en) 1996-11-28

Similar Documents

Publication Publication Date Title
EG20513A (en) Bicyclic tetrahydro pyrazolopyridines
IL115667A0 (en) Bicyclic tetrahydro pyrazolopyridines
HU9403364D0 (en) Imidazopyridine
ZA939433B (en) Imidazopyridines
HU9201781D0 (en) Bicyclic repamicines
ZA949664B (en) Imidazopyridines
EP0702671A4 (en) Bicyclic fibrinogen antagonists
HU9601789D0 (en) Pyrazolopyridine adenosine antagonists
AU4123893A (en) Imidazopyridines
AU3019192A (en) Imidazopyridines
ZA943996B (en) Imidazopyridines
ZA932459B (en) Imidazopyridines
ZA942543B (en) Tetrohydro beta-carbolines
ZA937875B (en) Imidazopyridines
EP0745086A4 (en) Tricyclic spiropiperidines
ZA947314B (en) Tricyclic derivatives
ZA931368B (en) Sulphonylbenzyl-substituted imidazopyridines
HU9500007D0 (en) Tricyclic cepheme derivatives
EP0417059A3 (en) Bicyclic tetrahydroxylated pyrrolizidines
ZA94990B (en) New imidazopyridines
IL119547A0 (en) Imidazopyridine compounds
ZA942352B (en) Spiropiperidine derivatives
ZA9410409B (en) Pyrazolopyridine compound
ZA934289B (en) Imidazopyridines.
GB9116309D0 (en) Bicyclic derivatives

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee